Stammdaten
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn's disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.
Unternehmen & Branche
| Name | Celularity Inc |
|---|---|
| Ticker | CELU |
| CIK | 0001752828 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | 151190105 |
|---|---|
| ISIN | US1511901050 |
| Typ | Common Stock |
| Marktkapitalisierung | 22,9 Mio. USD |
| Beta | 0,45 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 26,550,000 | -91,716,000 | -3.59 | 107,329,000 | -38,062,000 |
| 2025-09-30 | 10-Q | 5,284,000 | -23,076,000 | -0.88 | 114,239,000 | -20,094,000 |
| 2025-06-30 | 10-Q | 5,736,000 | -24,524,000 | -1.02 | 120,283,000 | -25,497,000 |
| 2025-03-31 | 10-Q | 11,426,000 | -19,754,000 | -0.84 | 128,876,000 | -5,506,000 |
| 2024-12-31 | 10-K | 54,220,000 | -57,892,000 | -2.64 | 132,682,000 | 8,837,000 |
| 2024-09-30 | 10-Q | 9,296,000 | -16,098,000 | -0.73 | 128,840,000 | 17,280,000 |
| 2024-06-30 | 10-Q | 12,111,000 | -6,488,000 | -0.30 | 135,494,000 | 27,811,000 |
| 2024-03-31 | 10-Q | 14,681,000 | -22,013,000 | -1.03 | 143,816,000 | 31,245,000 |
| 2023-12-31 | 10-K | 22,771,000 | -196,295,000 | -11.02 | 143,889,000 | 40,960,000 |
| 2023-09-30 | 10-Q | 3,786,000 | -93,876,000 | -4.98 | 157,192,000 | 30,247,000 |
| 2023-06-30 | 10-Q | 2,938,000 | -47,949,000 | -2.72 | 246,419,000 | 118,501,000 |
| 2023-03-31 | 10-Q | 3,935,000 | -64,017,000 | -4.12 | 362,416,000 | 155,628,000 |
| 2022-12-31 | 10-K | 17,975,000 | 14,192,000 | 0.95 | 401,066,000 | 198,901,000 |
| 2022-09-30 | 10-Q | 4,135,000 | 4,799,000 | 0.03 | 437,116,000 | 164,235,000 |
| 2022-06-30 | 10-Q | 3,776,000 | 47,826,000 | 0.32 | 429,337,000 | 150,150,000 |
| 2022-03-31 | 10-Q | 5,935,000 | -62,867,000 | -0.48 | 434,202,000 | 89,905,000 |
| 2021-12-31 | 10-Q | -100,118,000 | 414,128,000 | 99,418,000 | ||
| 2021-12-31 | 10-K | 21,335,000 | -100,118,000 | -1.49 | 414,128,000 | 99,418,000 |
| 2021-09-30 | 10-Q | 10,622,000 | 49,938,000 | 0.40 | 448,286,000 | 96,216,000 |
| 2021-06-30 | 10-Q | 3,197,000 | -64,477,000 | -2.69 | 128,415,406 | -648,205,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 676,650 | 0 | 676,650 | 751,082 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 160,190 | 0 | 160,190 | 177,843 | Neu | +100,0% | |
| BlackRock, Inc. | 114,855 | 0 | 114,855 | 127,488 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 77,657 | 0 | 77,657 | 86,199 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 61,200 | 0 | 61,200 | 67,932 | Neu | +100,0% | |
| STATE STREET CORP | 57,830 | 0 | 57,830 | 64,191 | Neu | +100,0% | |
| Valmark Advisers, Inc. | 49,983 | 0 | 49,983 | 55,481 | Neu | +100,0% | |
| HB Wealth Management, LLC | 40,415 | 40,415 | 0 | 53,752 | Unverändert | 0,0% | |
| NORTHERN TRUST CORP | 44,163 | 0 | 44,163 | 49,021 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 41,312 | 0 | 41,312 | 45,856 | Neu | +100,0% | |
| XTX Topco Ltd | 29,315 | 0 | 29,315 | 32,540 | Neu | +100,0% | |
| KEYNOTE FINANCIAL SERVICES LLC | 25,320 | 0 | 25,320 | 28,105 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 18,000 | 0 | 18,000 | 20,000 | Neu | +100,0% | |
| IPG Investment Advisors LLC | 17,169 | 0 | 17,169 | 19,058 | Neu | +100,0% | |
| Walleye Capital LLC | 835,194 | 0 | 835,194 | 13,614 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,727 | 0 | 11,727 | 13,017 | Neu | +100,0% | |
| IFP Advisors, Inc | 8,000 | 11,000 | -3,000 | 10,640 | Reduziert | -27,3% | |
| UBS Group AG | 6,744 | 5,256 | 1,488 | 6,045 | Aufgestockt | +28,3% | |
| SIMPLEX TRADING, LLC | 5,203 | 0 | 5,203 | 5,775 | Neu | +100,0% | |
| Tower Research Capital LLC (TRC) | 4,998 | 0 | 4,998 | 5,548 | Neu | +100,0% | |
| CITIGROUP INC | 4,951 | 0 | 4,951 | 5,496 | Neu | +100,0% | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 350,000 | 0 | 350,000 | 4,585 | Neu | +100,0% | |
| PEAK6 LLC | 171,363 | 0 | 171,363 | 2,785 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 2,500 | 0 | 2,500 | 2,775 | Neu | +100,0% | |
| Context Capital Management, LLC | 150,000 | 0 | 150,000 | 2,445 | Neu | +100,0% | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 150,800 | 0 | 150,800 | 2,443 | Neu | +100,0% | |
| SBI Securities Co., Ltd. | 1,868 | 0 | 1,868 | 2,073 | Neu | +100,0% | |
| CALDWELL SUTTER CAPITAL, INC. | 1,000 | 0 | 1,000 | 1,110 | Neu | +100,0% | |
| Corient Private Wealth LLC | 56,200 | 0 | 56,200 | 916 | Neu | +100,0% | |
| CoreCap Advisors, LLC | 500 | 500 | 0 | 665 | Unverändert | 0,0% | |
| Weaver Capital Management LLC | 11,609 | 11,609 | 0 | 511 | Unverändert | 0,0% | |
| HighMark Wealth Management LLC | 441 | 0 | 441 | 489 | Neu | +100,0% | |
| Clear Street Group Inc. | 11,713 | 0 | 11,713 | 191 | Neu | +100,0% | |
| Financial Perspectives, Inc | 171 | 0 | 171 | 190 | Neu | +100,0% | |
| Procyon Advisors, LLC | 11,500 | 0 | 11,500 | 187 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 99 | 0 | 99 | 110 | Neu | +100,0% | |
| JONES FINANCIAL COMPANIES LLLP | 82 | 0 | 82 | 91 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 28 | 0 | 28 | 31 | Neu | +100,0% | |
| United Financial Planning Group LLC | 19 | 0 | 19 | 21 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 16 | 0 | 16 | 18 | Neu | +100,0% | |
| DANSKE BANK A/S | 1 | 0 | 1 | 1 | Neu | +100,0% | |
| WOLVERINE ASSET MANAGEMENT LLC | 68 | 0 | 68 | 1 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| HB Wealth Management, LLC | 40,415 | 53,752 | 75.06 |
| IFP Advisors, Inc | 8,000 | 10,640 | 14.86 |
| UBS Group AG | 6,744 | 6,045 | 8.44 |
| CoreCap Advisors, LLC | 500 | 665 | 0.93 |
| Weaver Capital Management LLC | 11,609 | 511 | 0.71 |